Cure My Disease

Don't miss your cure!

 Log in / Sign up

VR workouts boost fitness in cystic fibrosis kids

NCT ID NCT05850351

Symptom relief Sponsor: Koç University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a 12-week virtual reality exercise program done at home could improve exercise capacity in children with cystic fibrosis. 36 kids aged 12-16 were split into two groups: one used VR headsets for team activities, the other did standard online exercises. The main goal was to see if the VR group walked farther in a 6-minute walk test.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

36 people

The number who actually took part.

Started

May 2023

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 16 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 12 and 16 years, * Clinical stability without disease exacerbations in the 4 weeks prior to their enrollment into the study * Having access to internet and parental or legal caregiver consent Exclusion Criteria: * Children with a pulmonary exacerbation in the previous 4 weeks, * Active pulmonary infection, * Evidence of pulmonary hypertension * Any cardiological, musculoskeletal, neurological or cognitive comorbidities that prevent exercise participation, * Behavioral ot intellectual difficulties that prevent participation in assessments or exercises provided remotely * Children with oxygen supplementation (daily continuous use or \> 2 L/min at night) * Lung transplant candidates

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cystic fibrosis in children are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cystic fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cystic fibrosis in children Telerehabilitation Virtual reality

Contacts and locations

Locations

  • Koc University School of Medicine

    Istanbul, 34010, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.